BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Riihilä P, Nissinen L, Knuutila J, Rahmati Nezhad P, Viiklepp K, Kähäri VM. Complement System in Cutaneous Squamous Cell Carcinoma. Int J Mol Sci 2019;20:E3550. [PMID: 31331124 DOI: 10.3390/ijms20143550] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Lu P, Ma Y, Wei S, Liang X. The dual role of complement in cancers, from destroying tumors to promoting tumor development. Cytokine 2021;143:155522. [PMID: 33849765 DOI: 10.1016/j.cyto.2021.155522] [Reference Citation Analysis]
2 Thind AS, Ashford B, Strbenac D, Mitchell J, Lee J, Mueller SA, Minaei E, Perry JR, Ch’ng S, Iyer NG, Clark JR, Gupta R, Ranson M. Whole genome analysis reveals the genomic complexity in metastatic cutaneous squamous cell carcinoma. Front Oncol 2022;12:919118. [DOI: 10.3389/fonc.2022.919118] [Reference Citation Analysis]
3 Zhu H, Yu X, Zhang S, Shu K. Targeting the Complement Pathway in Malignant Glioma Microenvironments. Front Cell Dev Biol 2021;9:657472. [PMID: 33869223 DOI: 10.3389/fcell.2021.657472] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Rahmati Nezhad P, Riihilä P, Knuutila JS, Viiklepp K, Peltonen S, Kallajoki M, Meri S, Nissinen L, Kähäri VM. Complement Factor D Is a Novel Biomarker and Putative Therapeutic Target in Cutaneous Squamous Cell Carcinoma. Cancers (Basel) 2022;14:305. [PMID: 35053469 DOI: 10.3390/cancers14020305] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Fijałkowska M, Koziej M, Antoszewski B. Detailed head localization and incidence of skin cancers. Sci Rep 2021;11:12391. [PMID: 34117314 DOI: 10.1038/s41598-021-91942-5] [Reference Citation Analysis]
6 Rahmati Nezhad P, Riihilä P, Piipponen M, Kallajoki M, Meri S, Nissinen L, Kähäri VM. Complement factor I upregulates expression of matrix metalloproteinase-13 and -2 and promotes invasion of cutaneous squamous carcinoma cells. Exp Dermatol 2021. [PMID: 33813765 DOI: 10.1111/exd.14349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Luo S, Wang M, Wang H, Hu D, Zipfel PF, Hu Y. How Does Complement Affect Hematological Malignancies: From Basic Mechanisms to Clinical Application. Front Immunol 2020;11:593610. [PMID: 33193442 DOI: 10.3389/fimmu.2020.593610] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Yuan SP, Li CX, Qin S, Wen J, Zhang XB, Tian X, Zhu CY, Li T, Huang JP, Zheng XH. High expression of disabled homolog 2-interacting protein contributes to tumor development and proliferation in cutaneous squamous cell carcinoma. Ann Transl Med 2020;8:1131. [PMID: 33240980 DOI: 10.21037/atm-20-5067] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Viiklepp K, Nissinen L, Ojalill M, Riihilä P, Kallajoki M, Meri S, Heino J, Kähäri VM. C1r Upregulates Production of Matrix Metalloproteinase-13 and Promotes Invasion of Cutaneous Squamous Cell Carcinoma. J Invest Dermatol 2021:S0022-202X(21)02379-4. [PMID: 34756877 DOI: 10.1016/j.jid.2021.10.008] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
10 Cives M, Mannavola F, Lospalluti L, Sergi MC, Cazzato G, Filoni E, Cavallo F, Giudice G, Stucci LS, Porta C, Tucci M. Non-Melanoma Skin Cancers: Biological and Clinical Features. Int J Mol Sci 2020;21:E5394. [PMID: 32751327 DOI: 10.3390/ijms21155394] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 13.5] [Reference Citation Analysis]
11 Palazzo E, Morasso MI, Pincelli C. Molecular Approach to Cutaneous Squamous Cell Carcinoma: From Pathways to Therapy. Int J Mol Sci 2020;21:E1211. [PMID: 32059344 DOI: 10.3390/ijms21041211] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Pentangelo G, Nisticò SP, Provenzano E, Cisale GY, Bennardo L. Topical 5% Imiquimod Sequential to Surgery for HPV-Related Squamous Cell Carcinoma of the Lip. Medicina (Kaunas) 2021;57:563. [PMID: 34199380 DOI: 10.3390/medicina57060563] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
13 Piipponen M, Nissinen L, Kähäri VM. Long non-coding RNAs in cutaneous biology and keratinocyte carcinomas. Cell Mol Life Sci 2020;77:4601-14. [PMID: 32462404 DOI: 10.1007/s00018-020-03554-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]